Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Whole genome analysis plays a critical role in the development of life-saving diagnostics, therapeutics, and vaccines, with growing interest in noncoding regions and Whole genome analysis plays a ...

Next-generation sequencing (NGS) has moved away from expensive runs and complicated workflows into a new era where benchtop instruments prioritize sustainability, accessibility, accuracy, and speed.

The field of genetic epidemiology has been revolutionized by recent advancements in next-generation sequencing technologies, as well as the development of ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Bir Hospital's genetic lab, which previously tested for limited hereditary conditions, is now preparing to expand services to include cancer and other genetic disorders.The hospital is set to ...